OSR HEALTH, INC. (OSRH) Current Ratio
- Current ratio · latest quarter: Value 0.18×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 0.18× | Current assets / current liabilities. $2.87M ÷ $15.73M ≈ 0.18× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 2.87M USD | Assets, Current |
| Current obligations | 15.73M USD | Liabilities, Current |
| Cash and equivalents | 1.50M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 188.80K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 594.29K USD | Inventory, Net |
| Payables | (m) | |
| Borrowing debt due within one year | 272.70K USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.87M | $15.73M | $1.50M | (m) | $188.80K | $594.29K | (m) | $272.70K | 0.18× |
| 2026-03-31 | $2.92M | $17.90M | $1.57M | (m) | $261.36K | $462.45K | (m) | $196.90K | 0.16× |
| 2025-12-31 | $2.82M | $17.17M | $1.70M | (m) | $319.30K | $196.43K | (m) | (m) | 0.16× |
| 2025-09-30 | $3.20M | $15.03M | $2.18M | (m) | $489.18K | $185.09K | (m) | (m) | 0.21× |
| 2025-06-30 | $2.88M | $15.86M | $1.58M | (m) | $742.78K | $198.83K | (m) | $630.60K | 0.18× |
| 2025-03-31 | $3.47M | $13.88M | $1.60M | (m) | $794.51K | $736.63K | (m) | $245.48K | 0.25× |
| 2024-12-31 | $2.33M | $3.46M | $341.54K | (m) | $904.46K | $922.11K | (m) | (m) | 0.67× |
| 2024-09-30 | $39.61K | $3.94M | $12.24K | (m) | (m) | (m) | (m) | (m) | 0.01× |
| 2024-06-30 | $166.83K | $3.42M | $119.12K | (m) | (m) | (m) | (m) | (m) | 0.05× |
| 2024-03-31 | $68.18K | $2.75M | $3.64K | (m) | (m) | (m) | (m) | (m) | 0.02× |
| 2023-12-31 | $22.63K | $2.04M | $15.42K | (m) | (m) | (m) | (m) | (m) | 0.01× |
| 2023-09-30 | $82.41K | $1.11M | $57.95K | (m) | (m) | (m) | (m) | (m) | 0.07× |
| 2023-06-30 | $58.98K | $541.37K | $1.18K | (m) | (m) | (m) | (m) | (m) | 0.11× |
| 2023-03-31 | $429.88K | $403.43K | $348.80K | (m) | (m) | (m) | (m) | (m) | 1.07× |
| 2022-12-31 | $124.50K | $1.26M | $124.50K | (m) | (m) | (m) | (m) | (m) | 0.10× |
| 2021-12-31 | $4.76K | $707.21K | $4.76K | (m) | (m) | (m) | (m) | (m) | 0.01× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |